Gabelli & Co Investment Advisers’s Teva Pharmaceuticals TEVA Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$407K	Hold	12,000	–	–	0.06%	204
2026 Q1	$361K	Hold	12,000	–	–	0.05%	194
2025 Q4	$375K	Sell	12,000 -3,000	-20%	-$73.9K	0.06%	177
2025 Q3	$303K	Hold	15,000	–	–	0.05%	188
2025 Q2	$251K	Hold	15,000	–	–	0.04%	197
2025 Q1	$231K	Hold	15,000	–	–	0.03%	190
2024 Q4	$331K	Hold	15,000	–	–	0.06%	153
2024 Q3	$270K	Buy	15,000 +5,000	+50%	+$87.5K	0.05%	143
2024 Q2	$163K	Buy	+10,000	New	+$154K	0.03%	193

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Gabelli & Co Investment Advisers's TEVA Position: Q2 2026 in Review

Gabelli & Co Investment Advisers held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 12,000 shares worth $407K. The position accounts for 0.06% of the portfolio, ranked #204.

Gabelli & Co Investment Advisers first reported a position in TEVA in Q2 2024 and has held it in 9 quarters since. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Gabelli & Co Investment Advisers held 12,000 shares of Teva Pharmaceuticals worth $407K as of Q2 2026.
Gabelli & Co Investment Advisers left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up 0.06% of Gabelli & Co Investment Advisers's portfolio in Q2 2026, its #204 holding.
Gabelli & Co Investment Advisers first reported a position in Teva Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.